Skip to main content
Fibromyalgia Stem Cell Therapy
Pain & Immune Medicine

Stem Cell Therapy for Fibromyalgia

Medically reviewed by
Professor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
Last reviewed
Next scheduled review

How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards

Advanced MSC treatments targeting systemic inflammation, normalizing pain signaling pathways, and addressing the root causes of widespread chronic pain and fatigue.

Can stem cell therapy help fibromyalgia?

Mesenchymal stem cell therapy is not an approved treatment for fibromyalgia. Direct controlled evidence in fibromyalgia is very limited. Established multimodal care — graded exercise, cognitive behavioural therapy, sleep and pain management, and appropriate medication such as duloxetine, pregabalin or amitriptyline — remains the evidence-based path. Regenerative options here are considered only alongside a specialist pain plan, not as replacement.

Key facts

Approval status
Not approved for fibromyalgia
Evidence
Very limited controlled trials in this indication
Standard care
Graded exercise, CBT, sleep management, duloxetine/pregabalin/amitriptyline

What we know

  • Multimodal care including graded exercise and CBT has the strongest evidence in fibromyalgia.

What remains uncertain

  • Whether MSC administration reproducibly changes fibromyalgia impact scores versus multimodal care.

Medically reviewed questions

No. Fibromyalgia responds best to multimodal, longer-term care.

No — approved therapies have evidence; discuss any change with your specialist.

For many patients yes, but pacing is important; work with a physiotherapist experienced in fibromyalgia.

This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.

Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy

Evidence at a glance — Fibromyalgia

A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.

Human studies available?
Limited
Randomised trials?
None identified
Main outcomes studied
  • Pain and tender points
  • Fatigue
  • Sleep
  • Quality of life
Long-term evidence
Very limited
Regulatory approval for this indication
  • United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
  • European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
  • United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
  • Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
Role at our centre
Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it

What kind of evidence exists

  • Mechanism (laboratory): Documented
  • Animal / preclinical: Documented
  • Early human (phase 1/2, uncontrolled): Documented
  • Controlled human (randomised or sham-controlled): Not established
  • Regulatory approval: Not established

Sources

Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.

Evidence last reviewed: Next scheduled review: Medical reviewer: Prof. Dr. Erdal KaraözRead our editorial and evidence policy

This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.

Medically reviewed by Prof. Dr. Erdal Karaöz
Share:
Summarize with AI:
Understanding the Condition

What is Fibromyalgia?

Fibromyalgia is a complex chronic pain condition affecting approximately 2-4% of the global population, predominantly women. It is characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, memory issues ('fibro fog'), and heightened pain sensitivity.

While the exact cause remains under research, fibromyalgia involves central sensitization, neuroinflammation, and immune system dysregulation. Traditional treatments focus on symptom management with medications that often have significant side effects. MSC therapy offers a novel approach by addressing the underlying inflammatory and immune dysfunction.

At StemCell Longevita, we use Wharton's jelly-derived MSCs that provide powerful anti-inflammatory and immunomodulatory effects, targeting the root causes of fibromyalgia rather than just masking symptoms.

Ideal Candidates

  • Patients diagnosed with fibromyalgia experiencing widespread pain
  • Those with chronic fatigue and sleep disturbances
  • Patients who have not responded adequately to conventional medications
  • Individuals experiencing cognitive difficulties ('fibro fog')
  • Those seeking a treatment approach that addresses root causes
Key Benefits

How Stem Cell Therapy Helps Fibromyalgia

Pain Reduction

MSCs reduce neuroinflammation and systemic inflammation, helping normalize the overactive pain signaling pathways that cause widespread fibromyalgia pain.

Energy Restoration

By reducing the chronic inflammatory burden and improving cellular function, many patients experience significant improvements in energy levels and reduced fatigue.

Sleep Quality

Anti-inflammatory effects of MSC therapy help improve sleep architecture, reducing insomnia and promoting more restorative sleep patterns.

Cognitive Clarity

MSC-derived neurotrophic factors help reduce brain fog, improving concentration, memory, and mental clarity that fibromyalgia patients often struggle with.

Your Journey

Treatment Process

Your step-by-step treatment journey at StemCell Longevita

01

Pain & Symptom Assessment

Comprehensive evaluation of pain distribution, tender points, fatigue levels, sleep quality, and cognitive function.

02

Personalized Protocol

Custom treatment plan addressing specific symptom profile, pain severity, and overall health status.

03

MSC Preparation

Wharton's jelly MSCs prepared in our GMP-certified lab with 97% viability for optimal anti-inflammatory potency.

04

IV Administration

Intravenous MSC delivery for systemic anti-inflammatory and immunomodulatory effects throughout the body.

05

Follow-Up Care

Post-treatment monitoring with pain assessments at 1, 3, and 6 months to track symptom improvement progression.

Patient Experiences

Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul

"My rheumatologist was surprised by the improvement. I can hold my grandchildren's hands again without wincing — that means everything to me."

Before:Severe joint swelling in hands and wrists, unable to open jars or write, on immunosuppressants
After:Joint swelling reduced by 70%, writing and cooking again, medication dose halved
Sarah L.
United Kingdom·Rheumatoid Arthritis

"Lupus controlled my life for a decade. After treatment in Istanbul, I travelled to three countries in one month — something unimaginable a year ago."

Before:Debilitating fatigue, skin rashes, kidney involvement requiring high-dose steroids
After:Energy levels significantly improved, skin clear, steroid dose reduced by 60%
Anna B.
Sweden·Systemic Lupus (SLE)
Common Questions

Frequently Asked Questions

MSCs reduce the systemic inflammation and neuroinflammation that drive fibromyalgia pain. They modulate the overactive immune system, repair damaged tissue, and help normalize pain signaling pathways, addressing root causes rather than just masking symptoms.

Patients commonly report significant reduction in widespread pain, improved energy levels, better sleep quality, reduced brain fog, decreased tender point sensitivity, and improved mood and overall quality of life.

Most fibromyalgia patients notice initial improvements within 2-4 weeks, with progressive benefits continuing for 3-6 months as the anti-inflammatory and tissue repair effects develop fully. Many patients experience lasting improvements of 12-18 months or longer.
Free PDF Guide

Download Our Free Fibromyalgia Guide

Get our comprehensive patient guide with detailed treatment information, expected outcomes, and FAQs — all in one downloadable PDF.

Take the First Step

Ready to Explore Fibromyalgia Treatment?

Schedule a free consultation with our medical team to discuss your condition and learn how stem cell therapy may help.